OTCBB:REPCF

Replicel Life Sciences Stock Signals

etoro logo Buy REPCF
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 03, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for RepliCel Life Sciences Inc.

General

Signal Type Signal Value Data
Score 0.000 111 days ( 0 %
Last Price $0.0001 0 %
Performance History
7 Days
$0.0001 $0.0001
0%
30 Days
$0.0001 $0.0001
0%
12 Mos
$0.0020 $0.0001
-95.00%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0001 - $0.0001
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jun 02, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 59.84
Signal Type Signal Value Importance Data
Trend - 12 mos -24.56 % Very High Width: 479.62 %
Pred. range - 12 mos N/A - $0.0259 High -100.00 % - 25,764.72 %
Short MA 12 mos Buy Very High Dec 23, 2025 - 111 days
Long MA 12 mos Buy Very High Apr 20, 2026 - 32 days
Short/Long MA 12 mos Buy Very High Apr 20, 2026 - 32 days
Pivot Long Buy Low Dec 03, 2025 - 125 days
RSI Long Pivot Signal Sell Low Jan 08, 2026 - 101 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT REPLICEL LIFE SCIENCES INC.
RepliCel Life Sciences
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin;...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE